Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ryangyeo Kim"'
Autor:
Xin Xia, Kevin Pethe, Ryangyeo Kim, Lluis Ballell, David Barros, Jonathan Cechetto, HeeKyoung Jeon, Kideok Kim, Alfonso E. Garcia-Bennett
Publikováno v:
Nanomaterials, Vol 4, Iss 3, Pp 813-826 (2014)
Tuberculosis is a major problem in public health. While new effective treatments to combat the disease are currently under development, they tend suffer from poor solubility often resulting in low and/or inconsistent oral bioavailability. Mesoporous
Externí odkaz:
https://doaj.org/article/c0c397820ef74e4e9caf89b746b30f75
Autor:
Jinsun Jeong, Guehye Kim, Da Eun Park, Ryangyeo Kim, Minjeong Woo, Vincent Delorme, Jichan Jang
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
New and improved treatments for tuberculosis (TB) are urgently needed. Recently, it has been demonstrated that verapamil, an efflux inhibitor, can reduce bacterial drug tolerance caused by efflux pump activity when administered in combination with av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc350a55dff4ea64fd453a8c648f30f
https://doi.org/10.1128/aac.02637-16
https://doi.org/10.1128/aac.02637-16
Autor:
Kideok Kim, Alfonso E. Garcia-Bennett, Jonathan Cechetto, Xin Xia, Ryangyeo Kim, Lluis Ballell, David Barros, Kevin Pethe, Heekyoung Jeon
Publikováno v:
Nanomaterials, Vol 4, Iss 3, Pp 813-826 (2014)
Nanomaterials
Nanomaterials; Volume 4; Issue 3; Pages: 813-826
Nanomaterials
Nanomaterials; Volume 4; Issue 3; Pages: 813-826
Tuberculosis is a major problem in public health. While new effective treatments to combat the disease are currently under development, they tend suffer from poor solubility often resulting in low and/or inconsistent oral bioavailability. Mesoporous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e661e5df0ff323d6bffd649e3c6acc
http://www.mdpi.com/2079-4991/4/3/813
http://www.mdpi.com/2079-4991/4/3/813
Autor:
Taegwon Oh, Young-Mi Kim, Dongsik Park, Yoojin Cho, Seung-Ae Yim, Priscille Brodin, Honggun Lee, Jan Jiricek, Zaesung No, Victoria Jones, Sang Nae Cho, Sujin Ahn, Ryangyeo Kim, Thierry Christophe, Se Yeon Kim, Seungbin Lim, Min Jung Seo, Pablo Bifani, Sung-Jun Han, Haejin Kwon, Seijin Park, Jonathan Cechetto, Jiyoun Nam, Junghwan Kim, Hee Kyoung Jeon, Jaeseung Kim, René Wintjens, John R. Walker, Mooyoung Seo, Jungjun Kim, Sunhee Kang, Adeline C. Y. Chua, Anne J. Lenaerts, Hang Ohuong Pham, Hwankyu Kang, Inhee Choi, Mary Jackson, Kevin Pethe, Kiyean Nam, Yoonae Ko, Yunhee Jang, Saeyeon Lee, Whitney Barnes, Ulf Nehrbass, Mahesh Nanjundappa, Sylvie Alonso, Bee Huat Tan, Marie Kempf, Srinivasa P. S. Rao, Ju-Young Jung, Soohyun Oh, Jichan Jang, Jinhwa Lee, Chun-Taek Oh, Jeong Jea Seo
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2013, 19 (9), pp.1157-1160. ⟨10.1038/nm.3262⟩
Nature Medicine, Nature Publishing Group, 2013, 19 (9), pp.1157-1160. ⟨10.1038/nm.3262⟩
International audience; New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38059c467c4a55442a71d3dda7fd1c8
https://hal.univ-angers.fr/hal-03333814
https://hal.univ-angers.fr/hal-03333814
